After a patient has surgery for pancreatic cancer, post-operative chemotherapy and/or radiotherapy may be recommended for certain patients who may be at higher risk for recurrence. This calculator will estimate the additional benefit from adjuvant therapy, based on specific risk factors for a given patient.
Enter details below for a patient who has had surgery for pancreatic cancer to estimate the benefit from post-operative chemotherapy or chemoradiotherapy.
This online nomogram is based on a log-normal survival model built from a series of pancreatic cancer patients treated at OHSU. For more information, see Bicquart C, El Youssef R, Wissel AR, Sheppard BC, Billingsley KG, Thomas CR, Wang SJ. A Nomogram for Predicting the Benefit of Adjuvant Therapy for Resected Pancreatic Ductal Adenocarcinoma, American Society of Radiation Oncology Annual Meeting, Miami, FL, 2011.